CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics
CytomX Therapeutics, Inc. (CTMX)
Today's Latest Price: $8.12 USD
0.06 (0.74%)
Updated Jun 2 4:00pm
Add CTMX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
CTMX Stock Summary
- CytomX Therapeutics Inc's stock had its IPO on October 8, 2015, making it an older stock than merely 16.12% of US equities in our set.
- Of note is the ratio of CytomX Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 10.78% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for CytomX Therapeutics Inc is higher than it is for about merely 15.06% of US stocks.
- Stocks that are quantitatively similar to CTMX, based on their financial statements, market capitalization, and price volatility, are CRUS, SYNA, CRBP, WVE, and MGNX.
- Visit CTMX's SEC page to see the company's official filings. To visit the company's web site, go to www.cytomx.com.
CTMX Daily Price Range
CTMX 52-Week Price Range
CTMX Stock Price Chart More Charts
CTMX Price/Volume Stats
| Current price | $8.12 | 52-week high | $15.44 |
| Prev. close | $8.06 | 52-week low | $3.60 |
| Day low | $7.78 | Volume | 565,915 |
| Day high | $8.18 | Avg. volume | 551,503 |
| 50-day MA | $9.31 | Dividend yield | N/A |
| 200-day MA | $7.79 | Market Cap | 372.89M |
CytomX Therapeutics, Inc. (CTMX) Company Bio
CytomX Therapeutics develops a novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology. The company was founded in 2008 and is based in San Francisco, California.
Loading social stream, please wait...